// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A case of cyclic cushing’s disease – cortisol surfing; catching the cortisol wave!

Mark Sutton-Smith - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Polycystic Ovary Syndrome

Hydrocortisone

Observational study of aetiology, efficacy of treatment and outcomes of hyponatraemia following pituitary surgery in a major neurosurgical centre

Ziad Hussein - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ambulance alert system enabling pre-hospital parenteral steroids for patients with adrenal insufficiency

Sam Westall - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Addison's disease

Hydroxyzine

Hypothyroidism in utero suppresses pituitary-adrenal function in the ovine fetus near term: Implications for fetal maturation and the timing of birth

Emily Camm - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypothyroidism

Lyothyronine

Immunomodulatory and anti-diabetic actions of a structurally-modified analogue of esculentin-2CHa isolated from the skin secretion of the frog, lithobates chiricahuensis (ranidae)

Opeolu Ojo - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

11-Ketotestosterone is the Predominant Androgen in Castration Resistant Prostate Cancer

Gido Snaterse - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Dexamethasone

An audit of monitoring of fetus in pregnant women with hyperthyroidism

Monzoor Quader - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperthyroidism

Methadone hydrochloride

Upregulation of HLA class I and antiviral immune responses in graves’ disease

Therese Weider - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pre-operative full blood count, C-reactive protein and serum inflammation-based scores may predict aggressive or refractory disease in patients with pituitary adenomas

Pedro Marques - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Systemic inflammation

Glucocorticoid

First in man study of oral native testosterone in hypogonadal men shows physiological testosterone levels in fed and fasted state

John Newell-Price - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cytochrome P450 (CYP) 2W1 affect steroid secretion in adrenocortical cell line and tumor tissues

Barbara Altieri - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

forskolin

Misdiagnosis of phaeochromocytoma with multiple cerebral infarcts and complex arrhythmias, failure “to think of it”

Genevieve Tellier - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Bisoprolol

A case of severe asymptomatic hypercalcaemia in IgG kappa multiple myeloma, focal bone disease and inappropriately normal PTH as a differential diagnostic dilemma

Yuliya Manova - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Multiple Myeloma

Zoledronic acid

ANALYSIS OF HEMOPHILIA PATIENT IDENTIFICATION IN DIFFERENT ECONOMIC SETTINGS

E. Tootoonchian - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

CONCOMITANT USE OF ADVATE® AND EMICIZUMAB IN PATIENTS WITH HAEMOPHILIA A: RESULTS AND ANALYSIS FROM A UK NEQAS BC EMICIZUMAB EXERCISE

I. Jennings - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Advate

EQUITY IN THE USE OF PROPHYLAXIS IN CHILDREN WITH SEVERE HEMOPHILIA

E. Tootoonchian - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

ROTEM ASSAY CONDITIONS SENSITIVE TO CONCIZUMAB

C. Augustsson - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

FVIII

THE IMPORTANCE OF GENETIC VARIANT DATABASES IN INTERPRETIVE REPORTING FOR HERITABLE BLEEDING DISORDERS

I. Jennings - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

SUBCUTANEOUS MARZEPTACOG ALFA (ACTIVATED) IS EFFECTIVE FOR ON‐DEMAND TREATMENT OF SPONTANEOUS BLEEDING IN HEMOPHILIA A RATS

T. Knudsen - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemophilia

CB-813

7TH INTERIM ANALYSIS OF ANTIHEMOPHILIC FACTOR (RECOMBINANT) AND JOINT HEALTH IN PATIENTS WITH HEMOPHILIA A: AHEAD INTERNATIONAL

K. Khair - European Association for Haemophilia and Allied Disorders (EAHAD) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

Antihemophilic factor

Copyright © 2026. QuantiNova All rights reserved